"Neoplasm Invasiveness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
| Descriptor ID |
D009361
|
| MeSH Number(s) |
C04.697.645 C23.550.727.645
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Invasiveness".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Invasiveness".
This graph shows the total number of publications written about "Neoplasm Invasiveness" by people in this website by year, and whether "Neoplasm Invasiveness" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 5 | 5 |
| 2000 | 0 | 10 | 10 |
| 2001 | 1 | 9 | 10 |
| 2002 | 0 | 6 | 6 |
| 2003 | 0 | 15 | 15 |
| 2004 | 2 | 7 | 9 |
| 2005 | 3 | 14 | 17 |
| 2006 | 1 | 13 | 14 |
| 2007 | 4 | 19 | 23 |
| 2008 | 4 | 22 | 26 |
| 2009 | 1 | 15 | 16 |
| 2010 | 0 | 18 | 18 |
| 2011 | 3 | 19 | 22 |
| 2012 | 1 | 22 | 23 |
| 2013 | 4 | 27 | 31 |
| 2014 | 3 | 24 | 27 |
| 2015 | 1 | 29 | 30 |
| 2016 | 2 | 30 | 32 |
| 2017 | 2 | 32 | 34 |
| 2018 | 1 | 22 | 23 |
| 2019 | 0 | 21 | 21 |
| 2020 | 0 | 15 | 15 |
| 2021 | 1 | 14 | 15 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 6 | 6 |
| 2024 | 2 | 11 | 13 |
| 2025 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Invasiveness" by people in Profiles.
-
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature. 2025 Oct; 646(8084):462-473.
-
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer. Cell Rep Med. 2025 Aug 19; 6(8):102255.
-
PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. Int J Urol. 2025 Sep; 32(9):1195-1202.
-
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Gu?rin-unresponsive Non-muscle-invasive Bladder Cancer. Eur Urol. 2025 Nov; 88(5):430-434.
-
Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study. Int J Urol. 2025 Aug; 32(8):1007-1013.
-
Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer. Ann Surg Oncol. 2025 May; 32(5):3098-3105.
-
Helicobacter pylori virulence factor CagA promotes Snail-mediated epithelial-mesenchymal transition and invasive behavior by downregulating Semaphorin 5A in gastric epithelial cells. Biochem Biophys Res Commun. 2025 03 01; 750:151421.
-
Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancer. Expert Opin Biol Ther. 2025 Jan-Feb; 25(2):149-159.
-
Confined cell migration along extracellular matrix space in vivo. Proc Natl Acad Sci U S A. 2025 Jan 07; 122(1):e2414009121.
-
Long-Term Outcomes of Neoadjuvant Intraarterial Chemotherapy for Locally Invasive Lacrimal Gland Carcinoma ex Pleomorphic Adenoma. Ophthalmic Plast Reconstr Surg. 2025 Jul-Aug 01; 41(4):432-438.